期刊文献+

甲状旁腺癌的诊断与治疗(附5例报告) 被引量:4

The Diagnosis and Treatment of Parathyroid Carcinoma
原文传递
导出
摘要 目的:总结和探讨甲状旁腺癌的诊断和治疗方法。方法:回顾性总结本院5例甲状旁腺癌的临床资料。结果:5例患者术前颈部均扪及质硬包块,平均血钙浓度为3.82mmol/L,平均PTH浓度为153.6pmol/L,4例术中发现周围浸润表现。5例中4例同时行甲状旁腺肿瘤和同侧甲状腺腺叶切除,1例仅行甲状旁腺肿瘤切除。5例术后均诊断为甲状旁腺癌。术后4例得到随访,时间4月~5年。其中2例术后无复发;1例于术后半年局部复发行患侧甲状腺切除,后无复发;1例因全身转移于术后8个月死亡。结论:甲状旁腺癌的诊断非常困难,异常高浓度血钙、血PTH及术中浸润表现和组织病理学特征是甲状旁腺癌诊断的重要依据99m^Tc—MIBI扫描及超声是病变定位的首选手段,肿瘤及其周围受侵组织的“整块切除”(en bloc resection)是首选的治疗方式。 Objective:To summarize and investigate the diagnosis and treatment of parathyroid carcinoma. Methods: The clinical data of five patients with parathyroid carcinoma were retrospectively studied. Results: Five patients had palpable and firm neck mass,the mean calcium level of 5 patients was 3.82 mmol/L,the mean parathyroid hormone level was 153.6 pmol/L, four patients had manifestations of invasion in operation. Parathyroid carcinoma was diagnosed definitively in five patients. Parathyroidectomy and ipsilateral thyroidectomy was performed in four patients, and parathroidectomy was performed in one patient. Four patients were followed up for four months to five years. Two patients survival without recurrence,one patient had recurrence six months post operation, one patient died of the metastasis eight months later after operation. Conclusion: The diagnosis of parathyroid carcinoma is very difficult. Extremely high level of calcium and parathyroid hormone and the manifestations of invasion in operation and histopathologic feature are key points to diagnosis of parathyroid carcinoma. 99m^Tc-MIBI scintigraphy and uhrasonograph were preferred methods for localization. En bloc resection of the carcinoma was the preferred surgical approach.
出处 《华西医学》 CAS 2009年第3期579-582,共4页 West China Medical Journal
关键词 甲状旁腺癌 诊断 治疗 parathyroid carcinoma diagnosis treatment
  • 相关文献

参考文献17

  • 1RAWAT N,KHETAN N, WILLIAMS DW,et al. Parathyroid carcinoma[J]. B J Surg,2005,92(11) :1345-1353.
  • 2MONTENEGRO FL, TAVARES MR, DURAZZO MD, et al. Clinical suspicion and parathyroid carcinoma management[J]. Sao Paulo Med J,2006,124(1) :42--44.
  • 3周建平,田雨霖.中国人原发性甲状旁腺功能亢进10年文献回顾(1995~2004年)[J].中国普通外科杂志,2007,16(1):78-80. 被引量:44
  • 4ELIZABETH A, MITTENDOR F, MCHENRY CR. Parathyroid Carcinoma[J].Adv Anat Pathol,2005,12 : 53-61.
  • 5李进,肖海鹏.甲状旁腺癌研究进展[J].国外医学(内科学分册),2005,32(6):243-246. 被引量:21
  • 6KEBEBEW E. Parathyroid carcinoma[J].Curr Treat Options Oncol, 2001,2:347-354.
  • 7FERNANDEZ-RANVIER GG, KHANAFSHAR E, JENSEN K, et al. Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? [J].Cancer,2007,110(2):255 264.
  • 8THOMPSON SD,PRICHARD AJN. The management of parathyroid carcinoma[J].Curt Opin Otolaryngol Head Neck Surg, 2004, 12:93-97.
  • 9ERICKSON LA, LONG J, WOLLAR P, et al. Parathyroid hyperplasia,adenomas and carcinomas:differential expression of p27Kipl protein[J].Am J Surg Pathol, 1999,23 : 288-295.
  • 10STOJADINOVIC A, HOOS A,NISSAN A,et al. Parathyroid neoplasms: clinical, histopathological and tissue microarray-based molecular analysis[J]. Hum Pathol, 2003,34 : 54-64.

二级参考文献35

  • 1朱预,孟迅吾.甲状旁腺腺瘤单侧探查的经验[J].中华外科杂志,1993,31(10):605-608. 被引量:29
  • 2周建平,李晓莉,李昱骥,董明,孔凡民,郭克建,田雨霖.原发性甲状旁腺功能亢进35例诊治分析[J].中国普通外科杂志,2005,14(9):653-655. 被引量:19
  • 3Shane E. [J]. J Clin Endocrinol Metab,2001,86(2) :485-493.
  • 4Obara T,Fujimoto Y. [J]. World J Surg, 1991,15( 6 ) :738-744,.
  • 5Favia G,Lumachi F,Polistina F,et al. [J]. World J Surg, 1998,22 ( 12 ) : 1225-1230.
  • 6Vetto JT,Brennan MF,Woodruf J,et al. [ J ]. Surgery, 1993,114(5 ) :882-892.
  • 7Hundahl SA,Fleming ID,Fremgen AM,et al. [J].Cancer, 1999,86(3 ) :538-544.
  • 8Schantz A, Castleman B. [J]. Cancer, 1973,31( 3 ) :600-605.
  • 9Agarwal SK, Schrock E, Kester MB, et al. [J].Cancer Genet Cytogenet, 1998,106( 1 ) :30-36.
  • 10Kytola S, Farnebo F,Obara T, et al. [J]. Am J Pathol, 2000,157 ( 2 ) :579-586.

共引文献79

同被引文献32

  • 1李进,肖海鹏.甲状旁腺癌研究进展[J].国外医学(内科学分册),2005,32(6):243-246. 被引量:21
  • 2胡明华,盛勇,李仁志,朱家胜,芮景.甲状旁腺癌致甲状旁腺危象1例报告[J].中国实用外科杂志,2007,27(1):95-95. 被引量:2
  • 3周建平,田雨霖.中国人原发性甲状旁腺功能亢进10年文献回顾(1995~2004年)[J].中国普通外科杂志,2007,16(1):78-80. 被引量:44
  • 4Schott M,Feldkamp J,Schattenberg D,et al.Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate pulsed dendritic cells[J].Eur J E ndocrinol,2000,142 (3):300-306.
  • 5Bradwell AR,Harvey TC.Control of hypercalcaemia of parathyroid carcinoma by immunisation[J].Lancet,1999,353(9150):370-373.
  • 6Yamada T,Muguruma H,Yano S,et al.Intensifaction therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice[J].Mol Cancer Ther,2009,8(1):119-126.
  • 7Stephenson TJ.Prognostic and predictive factors in endocrine tumours[J].Histopathology,2006,48(6):629-643.
  • 8Montenegro FL,Tavares MR,Durazzo MD,et al.Clinical suspicion and parathyroid carcinoma management[J].Sao Panlo Med J,2006,124(1):42-44.
  • 9DeLelli RA.Parathyroid carcinoma:an overview[J].AdvAnat Pathol,2005,12(1):53-61.
  • 10Kebebew E.Parathyroid carcinoma,a care but important disorder for endocrinologists,primary care physicians,and endocrine surgeons[J].Thyroid,2008,18(4):385-386.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部